110 related articles for article (PubMed ID: 8306416)
1. Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.
Poplin EA; LoRusso P; Lokich JJ; Gullo JJ; Leming PD; Schulz JJ; Veach SR; McCulloch W; Baker L; Schein P
Cancer Chemother Pharmacol; 1994; 33(5):415-9. PubMed ID: 8306416
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.
Betticher DC; Anderson H; Ranson M; Meely K; Oster W; Thatcher N
Br J Cancer; 1995 Dec; 72(6):1551-5. PubMed ID: 8519676
[TBL] [Abstract][Full Text] [Related]
3. Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group.
Comella P; Biglietto M; Casaretti R; De Lucia L; Avallone A; Maiorino L; Di Lullo L; De Cataldis G; Rivellini F; Comella G
Oncology; 2001; 60(2):127-33. PubMed ID: 11244327
[TBL] [Abstract][Full Text] [Related]
4. UFT/leucovorin combined with mitomycin-C in metastatic colorectal Ca.
Jakobsen A
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):32-4. PubMed ID: 11098488
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin-C and capecitabine (MIXE) as salvage treatment in patients with refractory metastatic colorectal cancer: a retrospective study.
Saif MW; Kaley K; Brennan M; Garcon MC; Rodriguez G
Anticancer Res; 2013 Jun; 33(6):2743-6. PubMed ID: 23749935
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
Hartmann JT; Kanz L; Bokemeyer C
Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418
[TBL] [Abstract][Full Text] [Related]
8. Amifostine and chemotherapy-related thrombocytopenia.
Budd GT
Semin Oncol; 1996 Aug; 23(4 Suppl 8):49-52. PubMed ID: 8783667
[TBL] [Abstract][Full Text] [Related]
9. WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial.
Glover D; Glick JH; Weiler C; Hurowitz S; Kligerman MM
J Clin Oncol; 1986 Apr; 4(4):584-8. PubMed ID: 3007686
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
Bamias A; Papamichael D; Syrigos K; Pavlidis N
J Chemother; 2003 Jun; 15(3):275-81. PubMed ID: 12868555
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
Bozkurt O; Karaca H; Ciltas A; Kaplan MA; Benekli M; Sevinc A; Demirci U; Eren T; Kodaz H; Isikdogan A; Ozkan M; Buyukberber S
Asian Pac J Cancer Prev; 2014; 15(4):1845-9. PubMed ID: 24641419
[TBL] [Abstract][Full Text] [Related]
12. Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma.
Price TJ; Ross PJ; Hickish T; Tait D; Norman AR; Ford HE; Middleton G; Sumpter K; Hill M; Oates J; Cunningham D
Clin Colorectal Cancer; 2004 Feb; 3(4):235-42. PubMed ID: 15025796
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP; Forgeson G; Cunningham D; Saunders MP; Stockler MR; Chua Y; Zalcberg JR; Simes RJ; Price TJ
J Clin Oncol; 2010 Jul; 28(19):3191-8. PubMed ID: 20516443
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Green D; Bensely D; Schein P
Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials of WR-2721 and cis-platinum.
Glover D; Grabelsky S; Fox K; Weiler C; Cannon L; Glick J
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1201-4. PubMed ID: 2541121
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies.
Coia L; Krigel R; Hanks G; Comis R; Algazy K; Peters R; McCulloch W; Schien P
Int J Radiat Oncol Biol Phys; 1992; 22(4):791-4. PubMed ID: 1312076
[TBL] [Abstract][Full Text] [Related]
18. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
[TBL] [Abstract][Full Text] [Related]
19. Protection by WR-2721 of human bone marrow function following irradiation.
Constine LS; Zagars G; Rubin P; Kligerman M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1505-8. PubMed ID: 2428794
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma.
Delioukina ML; Prager D; Parson M; Hecht JR; Rosen P; Rosen LS
Cancer; 2002 Apr; 94(8):2174-9. PubMed ID: 12001114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
